Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...
TipRanks on MSN
Zimmer Biomet’s Knee Implant Study: A Market Game-Changer?
Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. The Persona OsseoTi Keel Compatibility Study, officially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback